Pillay D - Search Results

1

Drug-resistant HIV-1 in the semen of men receiving antiretroviral therapy with acute sexually transmitted infections.

Taylor S, Sadiq ST, Weller I, Kaye S, Workman J, Cane PA, Bennett J, Copas AJ, Drake SM, Pillay D. Taylor S, et al. Among authors: pillay d. Antivir Ther. 2003 Oct;8(5):479-83. Antivir Ther. 2003. PMID: 14640396

2

The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis.

Sadiq ST, Taylor S, Kaye S, Bennett J, Johnstone R, Byrne P, Copas AJ, Drake SM, Pillay D, Weller I. Sadiq ST, et al. Among authors: pillay d. AIDS. 2002 Jan 25;16(2):219-25. doi: 10.1097/00002030-200201250-00011. AIDS. 2002. PMID: 11807306

3

Minimal variation in T-20 binding domain of different HIV-1 subtypes from antiretroviral-naive and -experienced patients.

Xu L, Hué S, Taylor S, Ratcliffe D, Workman JA, Jackson S, Cane PA, Pillay D. Xu L, et al. Among authors: pillay d. AIDS. 2002 Aug 16;16(12):1684-6. doi: 10.1097/00002030-200208160-00016. AIDS. 2002. PMID: 12172092

4

Analysis of HIV-1 variation in blood and semen during treatment and treatment interruption.

Choudhury B, Pillay D, Taylor S, Cane PA. Choudhury B, et al. Among authors: pillay d. J Med Virol. 2002 Dec;68(4):467-72. doi: 10.1002/jmv.10247. J Med Virol. 2002. PMID: 12376952

5

HIV viral load: the myth of the undetectable?

Pillay D. Pillay D. Rev Med Virol. 2002 Nov-Dec;12(6):391-6. doi: 10.1002/rmv.373. Rev Med Virol. 2002. PMID: 12410530 Review.

6

Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial).

Gibb DM, Walker AS, Kaye S, De Rossi A, Ait-Khaled M, Pillay D, Muñoz-Fernandez MA, Loveday C, Compagnucci A, Dunn DT, Babiker AG. Gibb DM, et al. Among authors: pillay d. Antivir Ther. 2002 Dec;7(4):293-303. Antivir Ther. 2002. PMID: 12553485 Clinical Trial.

7

Identification of a transmission chain of HIV type 1 containing drug resistance-associated mutations.

Taylor S, Cane P, Hué S, Xu L, Wrin T, Lie Y, Hellmann N, Petropoulos C, Workman J, Ratcliffe D, Choudhury B, Pillay D. Taylor S, et al. Among authors: pillay d. AIDS Res Hum Retroviruses. 2003 May;19(5):353-61. doi: 10.1089/088922203765551700. AIDS Res Hum Retroviruses. 2003. PMID: 12803994

8

Drug resistance genotypes predict response to amprenavir-containing regimens in highly drug-experienced HIV-1-infected patients.

Sabin CA, Wilkins E, Murphy M, Fisher M, de Ruiter A, Easterbrook PJ, Leen C, Vlahakis E, Cane PA, Li X, Pillay D; UK Expanded Access Amprenavir Programme. Sabin CA, et al. Among authors: pillay d. Antivir Ther. 2003 Aug;8(4):301-8. Antivir Ther. 2003. PMID: 14518699

9

Drug resistance mutations in HIV-1.

Johnson VA, Brun-Vézinet F, Clotet B, Conway B, D'Aquila RT, Demeter LM, Kuritzkes DR, Pillay D, Schapiro JM, Telenti A, Richman DD; International AIDS Society-USA Drug Resistance Mutations Group. Johnson VA, et al. Among authors: d aquila rt, pillay d. Top HIV Med. 2003 Nov-Dec;11(6):215-21. Top HIV Med. 2003. PMID: 14724329 Free article. Review.

10

Surveillance of HIV antiretroviral drug resistance in treated individuals in England: 1998-2000.

Scott P, Arnold E, Evans B, Pozniak A, Moyle G, Shahmenesh M, White D, Shirley J, Cane P, Pillay D. Scott P, et al. Among authors: pillay d. J Antimicrob Chemother. 2004 Mar;53(3):469-73. doi: 10.1093/jac/dkh102. Epub 2004 Jan 28. J Antimicrob Chemother. 2004. PMID: 14749345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

732 results

Search Page